61 related articles for article (PubMed ID: 3407412)
1. Comparative studies on the central effects of the angiotensin II analogue (Sar1 azaVal3 Ile8) AT II.
Georgiev VP; Klusha VE; Getova DP; Petkov VD; Svirskis SV; Mutsenietse RK; Kambourova TS; Oppitz MZh; Ancans JE
Acta Physiol Pharmacol Bulg; 1988; 14(1):22-9. PubMed ID: 3407412
[TBL] [Abstract][Full Text] [Related]
2. Central effects of angiotensin II, its fragment and analogues.
Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies on the central effects of angiotensin II and of its fragments.
Klusha V; Georgiev VP; Petkov VD; Markovska VL; Svirskis SV; Mutzenietze RK; Anuans ZE
Acta Physiol Pharmacol Bulg; 1986; 12(2):7-13. PubMed ID: 3766165
[TBL] [Abstract][Full Text] [Related]
4. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
Georgiev V
Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
[TBL] [Abstract][Full Text] [Related]
5. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
Georgiev V; György L; Getova D; Markovska V
Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
Bravo EL; Khosla MC; Bumpus FM
Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
[TBL] [Abstract][Full Text] [Related]
7. Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors.
Georgiev V; Petkova B; Kambourova T
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):295-9. PubMed ID: 3398646
[TBL] [Abstract][Full Text] [Related]
8. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
Hata T; Ogihara T; Nakamaru M; Gotoh S; Masuo K; Saeki S; Kumagai A; Kumahara Y
Eur J Clin Pharmacol; 1982; 23(1):7-10. PubMed ID: 6751836
[TBL] [Abstract][Full Text] [Related]
9. Effects of two different angiotensin II antagonists on aldosterone secretion by isolated perfused rat zona glomerulosa cells.
Boscaro M; Al-Dujaili EA; Edwards CR
Endocrinology; 1981 Jun; 108(6):2381-4. PubMed ID: 6262059
[TBL] [Abstract][Full Text] [Related]
10. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
Tchekalarova J; Georgiev V
Neuropeptides; 2006 Oct; 40(5):339-48. PubMed ID: 17045647
[TBL] [Abstract][Full Text] [Related]
11. The pressor response to exogenous angiotensin I and its blockade by angiotensin II analogues in the American alligator.
Silldorff EP; Stephens GA
Gen Comp Endocrinol; 1992 Jul; 87(1):141-8. PubMed ID: 1624094
[TBL] [Abstract][Full Text] [Related]
12. Minaprine, a new drug with antidepressant properties.
Bizière K; Worms P; Kan JP; Mandel P; Garattini S; Roncucci R
Drugs Exp Clin Res; 1985; 11(12):831-40. PubMed ID: 3836113
[TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of angiotensin antagonists in normotensive rats.
Sen S; Tarazi RC; Bumpus FM
Clin Sci (Lond); 1979 May; 56(5):439-43. PubMed ID: 157829
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
15. Papaverine, drug-induced stereotypy and catalepsy and biogenic amines in the brain of the rat.
Kostowski W; Gajewska S; Bidzinski A; Hauptman M
Pharmacol Biochem Behav; 1976 Jul; 5(1):15-7. PubMed ID: 1033561
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the angiotensin II effects on the exploratory behavior of rats in open field. I. Interaction of angiotensin II with saralasin and catecholaminergic drugs.
Georgiev V; Getova D; Opitz M
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):297-301. PubMed ID: 3613758
[TBL] [Abstract][Full Text] [Related]
17. Interactions of angiotensin II with piracetam in exploratory behavior and convulsive-seizure threshold.
Georgiev V; Petkova B; Kambourova T; Opitz M
Acta Physiol Pharmacol Bulg; 1989; 15(1):70-5. PubMed ID: 2773651
[TBL] [Abstract][Full Text] [Related]
18. On some central effects of elymoclavine.
Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S
Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain.
Georgiev V; Stancheva S; Kambourova T; Getova D
Acta Physiol Pharmacol Bulg; 1990; 16(1):32-7. PubMed ID: 2392952
[TBL] [Abstract][Full Text] [Related]
20. Effects of dexfenfluramine on dopamine dependent behaviours in rats.
Thorat VM; Gaonkar RK; Bhosale KB; Balsara JJ
Indian J Physiol Pharmacol; 2005 Jan; 49(1):39-48. PubMed ID: 15881857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
